Zymeworks (ZYME) Other Operating Expenses (2022 - 2026)
Zymeworks (ZYME) posted Other Operating Expenses of $765000.0 for Q1 2026, down 71.38% sequentially from $2.7 million in Q4 2025, and down 77.97% YoY from $3.5 million in Q1 2025.
Analysis
Zymeworks (ZYME) Other Operating Expenses (2022 - 2026) Analysis & Trends
Zymeworks has reported Other Operating Expenses for 5 years, with the latest figure at $765000.0 in Q1 2026.
- Quarterly Other Operating Expenses fell 77.97% year-over-year to $765000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.1 million (down 43.17% YoY) and the FY2025 annual result came in at $12.8 million, down 37.58% from the prior year.
- Other Operating Expenses declined to $765000.0 in Q1 2026 per ZYME's latest filing, from $2.7 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $6.2 million in Q1 2024 and troughed at -$13000.0 in Q1 2022.
- A 5-year average of $3.4 million and a median of $3.8 million in 2025 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2023 and 2026: Other Operating Expenses jumped 33315.38% in 2023, then tumbled 77.97% in 2026.
- Over 5 years, Other Operating Expenses stood at $1.0 million in 2022, then jumped by 305.09% to $4.2 million in 2023, then grew by 4.96% to $4.4 million in 2024, then slumped by 39.61% to $2.7 million in 2025, then slumped by 71.38% to $765000.0 in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $765000.0, $2.7 million, and $3.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 10 | Zymeworks | 2.14 Bn | 1.87 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.11 Mn |
| Mar 31, 2026 | 765,000.00 |
| Dec 31, 2025 | 2.67 Mn |
| Sep 30, 2025 | 3.84 Mn |
| Jun 30, 2025 | 2.81 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Sep 30, 2024 | 4.58 Mn |
| Jun 30, 2024 | 5.27 Mn |
| Mar 31, 2024 | 6.22 Mn |
| Dec 31, 2023 | 4.22 Mn |
| Sep 30, 2023 | 5.66 Mn |
| Jun 30, 2023 | 4.62 Mn |
| Mar 31, 2023 | 4.32 Mn |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 2.48 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | -13,000.00 |